title: Diabetic ketoacidosis associated with clozapine treatment.
authors.forename: A
authors.initials: A
authors.lastname: Colli
authors.forename: M
authors.initials: M
authors.lastname: Cocciolo
authors.forename: F
authors.initials: F
authors.lastname: Francobandiera
authors.forename: F
authors.initials: F
authors.lastname: Rogantin
authors.forename: N
authors.initials: N
authors.lastname: Cattalini
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000188:drug therapy*; D003024:Clozapine / Q000009:adverse effects*; D016883:Diabetic Ketoacidosis / Q000139:chemically induced* / Q000188:drug therapy; D005500:Follow-Up Studies; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D011618:Psychotic Disorders / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D007328:Insulin; D003024:Clozapine